Brief: Voyager Therapeutics Reports Q1 2023 Financial And Operating Results
09/05/2023 13:05
May 9 (Reuters) - Voyager Therapeutics Inc VYGR.O :
* VOYAGER THERAPEUTICS REPORTS FIRST QUARTER 2023 FINANCIAL
AND
OPERATING RESULTS
* VOYAGER THERAPEUTICS INC- COLLABORATION REVENUE OF $150.5
MILLION FOR Q1 OF 2023, COMPARED TO $0.7 MILLION FOR SAME PERIOD
IN 2022
* VOYAGER THERAPEUTICS INC - QTRLY LOSS PER SHARE $ 2.94
Source text for Eikon: ID:nGNX7lnGKK
Further company coverage: VYGR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Voyager Therapeutics
See all newsBrief: Voyager Names Robin Swartz As President; Expected To Succeed As CEO In Q1 2027
Voyager Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Voyager Therapeutics Q2 collaboration revenue falls, net loss narrows
Brief: Voyager Therapeutics Q2 Net Income USD -24.473 Million
Voyager Therapeutics Inc expected to post a loss of 48 cents a share - Earnings Preview